Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel Pin1 inhibitors designed and tested by German researchers

Dec. 15, 2003

Roche researchers prepare and test new dimeric antitumor agents

Dec. 15, 2003

Nonhypercalcemic vitamin D3 analogue HY-11 shows promising antileukemic activity

Dec. 12, 2003

Antiangiogenic PKC-beta inhibitor identified at J&J

Dec. 12, 2003

Genta completes NDA submission for Genasense for malignant melanoma

Dec. 12, 2003

New preclinical and phase I data presented for CYC-202

Dec. 12, 2003

Grant supports matriptase inhibitor development at Curacyte

Dec. 12, 2003

Schering AG researchers claim new PLK inhibitors for cancer and other uses

Dec. 12, 2003

Palifermin improves quality of life in cancer patients with oral mucositis

Dec. 12, 2003

New PARP inhibitors described by KuDOS and Maybridge scientists

Dec. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...